|
08.11.2017 16:00:00
|
Array BioPharma To Present At The 2017 Stifel Healthcare Conference
BOULDER, Colo., Nov. 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the 2017 Stifel Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: | Stifel Healthcare Conference |
Presenter: | Andy Robbins, Chief Operating Officer |
Date: | Wednesday, November 15, 2017 |
Time: | 11:00 a.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-stifel-healthcare-conference-300551492.html
SOURCE Array BioPharma
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Array BioPharma Inc.mehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Array BioPharma Inc.mehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.